Abstract
Seven patients with idiopathic Parkinson's disease were enrolled in a ten week study to evaluate the efficacy of famotidine, an histamine H2-antagonist, in the treatment of bradyphrenia. Patients received famotidine 80 mg/day for a period of six weeks and were evaluated with neuropsychological tests. Overall, patients demonstrated improvement in variables measured. Some patients also reported an improvement in their motor symptoms.
| Original language | English |
|---|---|
| Pages (from-to) | 243-247 |
| Number of pages | 5 |
| Journal | Journal of Neural Transmission - Parkinson's Disease and Dementia Section |
| Volume | 9 |
| Issue number | 2-3 |
| DOIs | |
| State | Published - Jun 1995 |
| Externally published | Yes |
Keywords
- Famotidine
- Parkinson's disease
- bradyphrenia